COVID-19 Information



Coronaviruses are common viruses that usually cause a simple cold. When new strains of viruses emerge, they can cause more severe diseases, as seen with the recent novel coronavirus disease called Coronavirus disease 2019 (COVID-19). This coronavirus is called the Severe Acute Respiratory Syndrome 2 virus (SARS-CoV-2). This new virus and disease were the cause of the outbreak in Wuhan, China, starting in December 2019 and now has spread to many parts of the world.


AST Resources For Transplant Professionals 

FAQs for Organ Transplantation (Updated 6/18/20)

Recommendations and Guidance for Organ Donor Testing (Updated 7/8/20)

Medication Access and Drug Shortage Concerns During the COVID-19 Pandemic: Frequently Asked Questions (Updated 6/18/20)

AST Resources For Transplant Recipients and Candidates 

FAQs Regarding Return to School for Children after Solid Organ Transplant in the United States During the COVID-19 Pandemic (Posted on 7/27/2020)

Information for Transplant Recipients and Candidates / Spanish version (Updated 6/29/20)

COVID-19: Answering Your Transplant Questions Video #2 (Recorded on 8/24/20)

COVID-19: Answering Your Transplant Questions Video #1 (Recorded on 4/27/20)

Transplant Patient in a New COVID-19 World (Recorded on 5/15/20)

Natera Transplant Town Hall (includes a Q&A with George Lopez and Dr. Emily Blumberg) (Recorded on 6/22/20)

Town Hall Webinars

*NEW* Third COVID-19 Organ Donation and Transplantation Town Hall (Recorded on 5/11/20)

COVID-19 Special Module on Donor & Transplant Issues (4/17/20)

Second COVID-19 Organ Donation and Transplantation Town Hall - Full Video (Recorded on 4/13/20)

COVID-19 Organ Donation and Transplantation Town Hall - Full Video (Recorded on 3/23/20)

COVID-19 Resources for the Donation and Transplantation Community (Resource Handout - Updated 4/13/20)

Other Transplant Resources 


World Health Organization (WHO) Guidance for Health Workers

Centers for Disease Control and Prevention (CDC) Resources for Medical Professionals

Action Learning Network: COVID-19

Organ Donation 

AOPO Information Page

Joint statement on donation screening by CST and Canadian Blood Services

Position statement on local organ recovery during COVID-19 pandemic

UNOS COVID-19 Data and Resources

Other Resources 

Publicly accessible SARS-CoV-2/COVID-19 policies and procedures for the University of Washington in Seattle

Publicly accessible resource from ISHLT

ASTS Resources page

JAMA interview with Maurizio Cecconi in Milan

CMS Telehealth Resource

American Journal of Transplantation (AJT) AJT link with compiled COVID19 articles

TTS COVID-19 Dashboard

For Transplant Coordinators: Managing Patient and Family Concerns

AASLD’s COVID-19 and the Liver Resources

Weekly Articles From AST eNews
You may sign up for the eNews here. These articles are for informational purposes only and are not endorsed by the AST.

COVID-19 AJT Articles

Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019

Early impact of COVID‐19 on transplant center practices and policies in the United States

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)

The immunocompromised transplant recipient and SARS-CoV-2 infection

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Coronavirus disease 2019: Utilizing an ethical framework for rationing absolutely scarce health-care resources in transplant allocation decisions

COVID‐19 in Solid Organ Transplant Recipients: Initial Report from the US Epicenter

Transplant programmes during COVID‐19: Unintended consequences for health inequality

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement

Pharmacologic treatment of transplant recipients infected with SARS-CoV-2 considerations regarding therapeutic drug monitoring and drug-drug interactions

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Harnessing Our Humanity — How Washington’s Health Care Workers Have Risen to the Pandemic Challenge

Immunosuppression drug‐related and clinical manifestation of Coronavirus disease 2019: a therapeutical hypothesis

Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Coronaviruses and immunosuppressed patients. The facts during the third epidemic

Epidemiology of COVID-19 in a Long-Term Care Facility in King County, Washington

Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China 

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

COVID‐19: A Global Transplant Perspective on Successfully Navigating a Pandemic 

Coronavirus disease 2019: Implications of emerging infections for transplantation 

Epidemiological and Clinical Characteristics of Heart Transplant Recipients During the 2019 Coronavirus Outbreak in Wuhan, China: A Descriptive Survey Report